Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Cup

Research Leaders

7 sponsors active, led by Korle-Bu Teaching Hospital, Accra, Ghana

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT05444504Not ApplicableRecruitingPrimary

Effectiveness and Acceptability of Insertable Devices for Obstetric Fistula Management

NCT01891149CompletedPrimary

Ultrasonographic and Hormonal Characteristics of Malawian Women With and Without Obstetric Fistula

Showing all 2 trials

Research Network

Common Treatments

  • Cup1

Active Sponsors

  • Korle-Bu Teaching Hospital, Accra, Ghana1
  • University of North Carolina, Chapel Hill1
  • American College of Obstetricians and Gynecologists1
  • University of California, San Francisco1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top Investigators

Related Conditions

  • Fistula Vaginal1
  • Fistula1
  • Fistula Urinary1

Activity Timeline